Pavel Jansa Selected Research

Pavel Jansa Research Topics

Disease

30	Pulmonary Arterial Hypertension 05/2024 - 11/2011
29	Pulmonary Hypertension 08/2023 - 12/2008
4	Headache (Headaches) 01/2024 - 08/2013
4	Heart Failure 03/2016 - 08/2010
3	Atrial Fibrillation 05/2023 - 07/2020
3	Disease Progression 01/2021 - 12/2015
2	Tachycardia (Tachyarrhythmias) 05/2023 - 07/2020
2	Hemoptysis 02/2021 - 01/2021
2	Hemorrhage 02/2021 - 01/2021
2	Pulmonary Embolism 01/2021 - 01/2011
2	Hypotension (Low Blood Pressure) 01/2021 - 01/2021
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2017 - 03/2014
2	Venous Thromboembolism 11/2011 - 01/2011
1	Diarrhea 01/2024
1	Pain (Aches) 01/2024
1	Hypertrophy 08/2023
1	Cardiac Arrhythmias (Arrythmia) 05/2023
1	Dyspepsia (Indigestion) 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Cough 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Flushing 01/2017
1	Coronary Disease (Coronary Heart Disease) 03/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2016
1	Diastolic Heart Failure 11/2014
1	Nasopharyngitis 08/2013
1	Anemia 08/2013
1	Dyspnea (Shortness of Breath) 07/2013
1	Syncope (Fainting) 07/2013
1	Portal Hypertension 05/2013
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 03/2011
1	Pulmonary Valve Insufficiency (Insufficiency, Pulmonary Valve) 03/2011
1	Postoperative Pain 01/2008

Drug/Important Bio-Agent (IBA)

16	riociguatIBA 10/2021 - 07/2013
10	macitentanIBA 01/2024 - 08/2013
9	Endothelin Receptor AntagonistsIBA 01/2024 - 12/2008
8	Soluble Guanylyl CyclaseIBA 02/2021 - 07/2013
3	Phosphodiesterase 5 InhibitorsIBA 01/2024 - 04/2014
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2024 - 01/2019
3	ProstaglandinsIBA 07/2020 - 08/2013
3	Bosentan (Tracleer)FDA Link 01/2017 - 12/2008
3	pro-brain natriuretic peptide (1-76)IBA 01/2017 - 07/2013
2	Sildenafil Citrate (Viagra)FDA Link 05/2024 - 01/2017
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 08/2023 - 03/2021
2	treprostinil FDA Link 07/2023 - 01/2019
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021 - 01/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2014 - 07/2013
1	TabletsIBA 01/2024
1	Tadalafil (Cialis)FDA Link 01/2024
1	ralinepagIBA 01/2024
1	Anti-Arrhythmia AgentsIBA 05/2023
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	Epoprostenol ReceptorsIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2019
1	selexipagIBA 01/2018
1	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 01/2017
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 11/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2014
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2014
1	AnticoagulantsIBA 04/2014
1	Hormones (Hormone)IBA 03/2014
1	CytokinesIBA 05/2013
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2013
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 03/2011
1	phenylacetic dipalmitateIBA 03/2011
1	Pathogen-Associated Molecular Pattern MoleculesIBA 03/2011
1	Sufentanil (Sufenta)FDA LinkGeneric 01/2008

Therapy/Procedure

19	Endarterectomy (Thromboendarterectomy) 07/2023 - 12/2008
17	Therapeutics 01/2024 - 12/2008
1	Catheter Ablation 05/2023
1	Drug Therapy (Chemotherapy) 04/2014
1	Lung Transplantation 08/2013
1	Contraception (Birth Control) 01/2011
1	Hormonal Contraception 01/2011
1	Extracorporeal Membrane Oxygenation 08/2010